ZDHHC20 and pancreatic neoplasm: Phosphorylation, ubiquitination, and palmitoylation modifications have been reported for other ZDHHCs41,42, and we conjecture that post-translational modifications of the ZDHHC20 protein in pancreatic cancer may lead to the significance of the mRNA-protein expression difference and may further amplify its carcinogenicity.